Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Amgen
Woman and Man Max 99 years
Amgen (USA)
Update Il y a 5 ans
Treatment of advanced, relapsed chronic lymphocytic leukemia (CLL) with fludarabine, miroxantrone and cyclophosphamide combination therapy with or without granulocyte colony stimulating factor (G-CSF)
Not provided at time of registration
Country
Germany
organs
None
Specialty
None
Closed trial
More information
Woman and Man
Between 18 years
and 99 years
Amgen
Update Il y a 5 ans
Amgen 20050244 : Essai de phase 3 randomisé, double aveugle, comparant l’efficacité du dénosumab et de l’acide zolédronic chez des patients ayant un cancer avec métastases osseuses. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions]
A randomized, double-blind, multicenter study of denosumab compared with zoledronic acid (Zometa) in the treatment of bone metastases in subjects with advanced cancer (excluding breast and prostate ca...
Country
France
organs
Tout Cancer
,
Métastases osseuses
,
Myélomes
Specialty
Chimiothérapie
,
Thérapies Ciblées
Essai clos aux inclusions
More information
Woman and Man Max 99 years
Amgen S.A
Update Il y a 5 ans
Estudio abierto, de un solo grupo, de palifermin para la reducción de la mucositis en sujetos con linfoma no Hodgkin (LNH) o mieloma múltiple (MM) sometidos a quimioterapia a altas dosis y trasplante autólogo de células progenitoras de sangre periférica (CPSP)
Estimar la efectividad de palifermin administrado a una dosis de 60 mg/kg/día IV durante 3 días consecutivos antes del inicio del régimen de acondicionamiento y durante 3 días consecutivos después del...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 5 ans
A phase 2 biomarker study evaluating subjects with unresected, advanced melanoma treated with talimogene laherparepvec
To explore the correlation between a baseline immunoprofile (ie, intratumoral CD8+ cell density) and objective response rate (ORR) in subjects with unresected stage IIIB to IVM1c melanoma treated with...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 5 ans
A Study Assessing the Impact of Additional LDL-Cholesterol Reduction on Major Cardiovascular Events when AMG 145 is used in combination With Statin Therapy In Patients with Clinically Evident Cardiovascular Disease
To evaluate the effect of treatment with AMG 145, compared with placebo, on the risk for cardiovascular death, myocardial infarction, stroke, hospitalization for unstable angina, or coronary revascula...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man
Between 28 years and 18 years
Amgen
Update Il y a 5 ans
Étude RIALTO : étude d’accès élargi visant à évaluer la sécurité d’emploi et l’efficacité du blinatumomab chez les enfants et les adolescents ayant une leucémie aiguë lymphoblastique à précurseurs B réfractaire ou en rechute. [essai clos aux inclusions]
La leucémie aiguë lymphoblastique est un cancer du sang et de la moelle osseuse qui apparaît à la suite de modifications de l’ADN d’une cellule souche de la moelle osseuse en croissance qui donnera li...
Country
France
organs
Leucémies aiguës
Specialty
Pédiatrie
Essai clos aux inclusions
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 5 ans
Ensayo aleatorizado de fase 2 de quimiorradioterapia con o sin Panitumumab en sujetos con carcinoma de células escamosas de cabeza y cuello localmente avanzado y no resecado
Determinar, con una precisión preespecificada, la diferencia en la tasa de control locorregional (CLR) a los 2 años en sujetos que reciben panitumumab más quimiorradioterapia (PQRT) o solamente quimio...
Country
None
organs
None
Specialty
None
Closed trial
More information
Man
Between 18 years
and 99 years
Amgen
Update Il y a 5 ans
Amgen 20050103 : Essai de phase 3, randomisé, en double aveugle comparant l’efficacité du dénosumab à l’acide zolédronique dans le traitement de métastases osseuses chez les hommes ayant un cancer de la prostate réfractaire aux hormones. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions]
Cet essai de phase 3 randomisé a pour objectif d’évaluer la non-infériorité du dénosumab par rapport à l’acide zolédronique (Zometa®) dans le traitement de métastases osseuses chez des hommes atteints...
Country
France
organs
Prostate
,
Métastases osseuses
Specialty
Chimiothérapie
,
Thérapies Ciblées
Essai clos aux inclusions
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 5 ans
A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Cinacalcet HCl in Chronic Kidney Disease Subjects with Secondary Hyperparathyroidism Not Receiving Dialysis
To evaluate the efficacy of cinacalcet compared with placebo by determining the proportion of subjects achieving a mean reduction of ≥ 30% in intact parathyroid hormone (iPTH) during the efficacy asse...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 5 ans
Study to Evaluate Efficacy, Safety, and Pharmacokinetics of Denosumab in Children With Osteogenesis Imperfecta Estudio para evaluar la eficacia, seguridad y farmacocinética de denosumab en niños con osteogénesis imperfecta
To evaluate the effect of denosumab on lumbar spine bone mineral density (BMD) Z-score at 12 months, as assessed by dual-energy X-ray absorptiometry (DXA), in children 2 to 17 years of age with osteog...
Country
None
organs
None
Specialty
None
unknown
More information
Previous
12
13
14
15
16
17
18
19
20
21
Next